Inactive Instrument

SEM4 HLDG

SMFR

US18978W1099

Cm Life Sciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021

July 21, 2021 at 04:32 pm EDT

CM Life Sciences, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 1.277 million. Net income was USD 13.009 million. For the half year, operating loss was USD 3.123 million. Net loss was USD 45.462 million.

Latest news about SEM4 HLDG

SEM4 HLDG : Cowen Initiates Sema4 Holdings at Outperform Rating With $13 Price Target	21-09-30	MT
SEM4 HLDG : Jefferies Starts Sema4 Holdings at Buy with $13 Price Target	21-09-24	MT
Twist Bioscience : SomaLogic Form Partnership to Discover Novel Therapeutic Targets, Antibodies	21-08-18	MT
Sector Update: Health Care Stocks Rising This Afternoon	21-08-17	MT
Sector Update: Health Care Stocks Rising Tuesday, Resisting Downward Market Pull	21-08-17	MT
Sector Update: Health Care Stocks Flat To Lower Premarket Tuesday	21-08-17	MT
DJ Industrial : Wall Street Sees Downbeat Session, US Retail Sales Fall More Than Expected in July	21-08-17	MT
Update: Sema4 Q2 Net Loss Widens Despite Revenue Boost -- Shares Slump in Pre-Market	21-08-17	MT
SEM4 HLDG : Sema4 Q2 Net Loss Widens Despite Revenue Boost	21-08-16	MT
SEM4 HLDG : Earnings Flash (SMFR) SEMA4 Posts Q2 Revenue $46.9M	21-08-16	MT
CM Life Sciences III : Agree to Business Combination; Shares Rise Early	21-08-06	MT
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company	21-07-22	CI
CM Life Sciences, Inc.(NasdaqCM:CMLF) dropped from NASDAQ Composite Index	21-07-22	CI
Mount Sinai Genomics, Inc. completed the acquisition of CM Life Sciences, Inc. from CMLS Holdings LLC, Eli D. Casdin, Keith A. Meister and others in a reverse merger transaction.	21-07-21	CI
Cm Life Sciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-21	CI
Cm Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-24	CI
CM Life Sciences III Raises $552 Million in IPO	21-04-09	MT
Cm Life Sciences, Inc. Reports Earnings Results for the Half Year Ended December 31, 2020	21-03-30	CI
CM Life Sciences II : SomaLogic to Go Public Through Combination With SPAC	21-03-29	MT
CM Life Sciences : SomaLogic to merge with Keith Meister-backed SPAC in $1.23 bln deal	21-03-29	RE
CM Life Sciences : SomaLogic to go public through SPAC merger in $1.23 bln deal	21-03-29	RE
Market Chatter: CM Life Sciences II Reportedly Nears $1.25 Billion SPAC Merger Deal With SomaLogic	21-03-29	MT
News Highlights : Top Company News of the Day	21-03-28	DJ
SPAC trading pops deflate as 'exuberance and greed' depart	21-03-24	RE
CM Life Sciences II : REFILE-UPDATE 1-SPAC trading pops deflate as 'exuberance and greed' depart	21-03-24	RE

Chart SEM4 HLDG

Duration

Period

More charts

Company Profile

Sema4 Holdings Corp, formerly CM Life Sciences Inc., is a patient-centered health intelligence company, which is focused on advancing healthcare through data-driven insights. The Company applies artificial intelligence (AI) and machine learning to clinical and genomic data to build models of human health and defining individualized health trajectories. The Company's health intelligence platform, Centrellis enables users to generate complete understanding of disease and wellness and to provide science-driven solutions to the pressing medical needs. Its products include Noninvasive Prenatal Select, Expanded Carrier Screen, Natalis Newborn Screen and Sema4 Signal Oncology Solutions. Noninvasive Prenatal Select is a blood test for insight into the user's baby health from nine weeks into pregnancy. Expanded Carrier Screen is a carrier screen for inherited conditions. Natalis Newborn Screen is a home test that provides insight into user's baby health by screening childhood diseases.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+173.89%	6.65B
CHURCHILL CAPITAL CORP VII	+2.29%	981M
SCREAMING EAGLE ACQUISITION CORP.	+5.57%	928M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+20.36%	804M
ARES ACQUISITION CORPORATION II	+1.72%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
E7 GROUP	-2.15%	593M
ALTC ACQUISITION CORP.	+40.25%	552M

Shell Companies